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Abstract
Low levels of 25-hydroxy vitamin D (25(OH)D) are associated with cardiovascular diseases. Herein, we tested the hypothesis
that vitamin D deficiency could be a causal factor in atherosclerotic vascular changes and vascular calcification. Aortic root
sections of vitamin D receptor knockout (VDR
2/2) mice that were stained for vascular calcification and immunostained for
osteoblastic differentiation factors showed more calcified areas and a higher expression of the osteogenic key factors Msx2,
Bmp2, and Runx2 than the wild-type mice (P,0.01). Data from LDL receptor knockout (LDLR
2/2) mice that were fed
western diet with either low (50 IU/kg), recommended (1,000 IU/kg), or high (10,000 IU/kg) amounts of vitamin D3 over 16
weeks revealed increasing plasma concentrations of 25(OH)D (P,0.001) with increasing intake of vitamin D, whereas levels
of calcium and phosphorus in plasma and femur were not influenced by the dietary treatment. Mice treated with the low
vitamin D diet had more calcified lesions and a higher expression of Msx2, Bmp2, and Runx2 in aortic roots than mice fed
recommended or high amounts of vitamin D (P,0.001). Taken together, these findings indicate vitamin D deficiency as a
risk factor for aortic valve and aortic vessel calcification and a stimulator of osteogenic key factor expression in these
vascular areas.
Citation: Schmidt N, Brandsch C, Ku ¨hne H, Thiele A, Hirche F, et al. (2012) Vitamin D Receptor Deficiency and Low Vitamin D Diet Stimulate Aortic Calcification
and Osteogenic Key Factor Expression in Mice. PLoS ONE 7(4): e35316. doi:10.1371/journal.pone.0035316
Editor: Olivier Kocher, Harvard Medical School, United States of America
Received March 7, 2012; Accepted March 15, 2012; Published April 20, 2012
Copyright:  2012 Schmidt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grant 0315668A from the Federal Ministry of Education and Research of Germany. The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: gabriele.stangl@landw.uni-halle.de
Introduction
Vitamin D deficiency has become a widespread public health
problem [1]. Humans normally get vitamin D from sunlight
exposure, from their diets or dietary supplements. Seasonal
variations of ultraviolet (UV)-B light exposure, increasing indoor
activities, and the frequent use of sunscreens are reasons for the
low synthesis of cutaneous vitamin D. These people strongly
depend on dietary sources of vitamin D. Recent data, however,
revealed that the prevalence of inadequate vitamin D intake is very
high in large parts of Europe [2].
The classical role of calcitriol (1,25(OH)2D3), the bioactive form
of vitamin D3, is to maintain calcium homeostasis and to promote
bone mineralisation [3]. However, a growing body of evidence
suggests that vitamin D could also modify the risk for
cardiovascular diseases. Several longitudinal observational cohort
analyses found low plasma concentrations of 25(OH)D associated
with an increased risk for incident of cardiovascular diseases [4–8]
and observational studies found reduced cardiovascular mortality
in patients with chronic kidney disease that received calcitriol
[9,10]. Since atherosclerotic degeneration of blood vessels is often
the basic underlying pathology of cardiovascular outcomes, the
question arises whether vitamin D would have any causal role in
pathological vascular changes. Compared to the huge number of
association studies, there have been only few studies on the
mechanistic effects of vitamin D deficiency on the vascular wall.
Recent data from vitamin D receptor knockout (VDR
2/2) mice,
an animal model that emulates vitamin D deficiency [11], revealed
a far greater number of fibrotic lesions in the hearts of these mice
compared to those of the wild-type mice [12]. However, aortic
valves and blood vessels of VDR
2/2 mice had not been
investigated in this study. In a mouse model of chronic kidney
disease, activators of vitamin D receptor such as calcitriol and
paricalcitrol were effective in protection against aortic calcification
in dosages that normalize secondary hyperparathyoidism, whilst
higher dosages stimulated aortic calcification [13]. In 2010,
Takeda et al. demonstrated that orally administered calcitriol
reduced atherosclerotic lesion formation in ApoE null mice [14].
To our knowledge, the physiological impact of a lack of vitamin D,
and particularly a lack of its native form, as reflected by the 25-
hydroxy-vitamin D (25OHD) on vascular composition and
atherosclerotic plaque development remains largely unexplored.
The aim of the present work was to investigate aortic valve and
vessel composition in response to VDR deficiency by use of a
VDR
2/2 mouse model. Since, we were able to show, for the first
time, that VDR
2/2 mice compared to wild-type mice showed
detectable numbers of calcified spots in their aortic valves,
accompanied by an up-regulation of osteogenic key factors, we
wanted to examine whether the observable changes in calcification
are also seen in animals fed a low vitamin D diet. Therefore a
second experiment was conducted with LDL receptor knockout
(LDLR
2/2) mice that were investigated for aortic vessel
composition and protein expression in response to a low vitamin




Impact of VDR deficiency on body weight and blood
vessel composition. At the end of the feeding period the
VDR
2/2 mice weighed less than the WT mice (VDR
2/2:
22.963.3 g, WTRD: 26.161.5 g, WTND: 25.261.5 g; P,0.05).
Analysis of aortic root cross-sections revealed no detectable
atherosclerotic lesions in any of the mice. During preparation
and dissection of the blood vessels we noticed that aortas of
VDR
2/2 mice had been more fragile than those of the WT mice.
Von Kossa staining revealed that calcification areas of aortic
valves of VDR
2/2 mice were 4.7 times greater than those of the
WTRD mice, and 2.6 times greater than those of the WTND mice
(P,0.001; Figure 1). No significant differences in calcification
areas were observed between the two groups of WT mice.
Figure 1C demonstrate that VDR
2/2 mice had a markedly higher
number of calcified spots within the aortic cross section than WT
mice. The increased number of calcified spots was comprised by a
higher number of small (,10 mm
2), medium (10–100 mm
2) and
large (.100 mm
2) spots, respectively, compared to WT mice. The
total number of calcified spots and the number of small, medium
and large-sized spots were comparable between the two WT
groups.
Impact of VDR deficiency on osteoblast differentiation
factors in aortic roots. To gain insight into the mechanisms
underlying the effect of VDR deficiency on vascular calcification,
aortic valve sections were immunohistochemically characterised for
osteoblast differentiation factors. As shown in Figure 2, VDR
2/2
mice had 3 to 6 times higher protein levels of Bmp2 (P,0.001),
Msx2 (P,0.001), and Runx2 (P,0.001) than WT mice. No
differences in Bmp2, Msx2, and Runx2 were observed between
WTRD and WTND mice, respectively (Figure 2).
Plasma concentration of calcium was lower in the VDR
2/2
mice than in the WT mice (VDR
2/2: 1.7760.24 mmol/L,
WTRD: 2.2860.04 mmol/L, WTND: 2.3060.07 mmol/L;
P,0.001). Circulating concentration of total phosphorus (organic
and inorganic) in the VDR
2/2 group was higher than in the WT
group fed the normal calcium diet (VDR
2/2: 6.3760.25 mmol/
L, WTRD: 6.1260.44 mmol/L, WTND: 5.6260.67 mmol/L;
P,0.05). However, plasma concentrations of inorganic phosphate
were not different between the three groups of mice (VDR
2/2:
1.6960.26 mmol/L, WTRD: 1.6360.32 mmol/L, WTND:
1.6960.19 mmol/L).
Study 2
Impact of vitamin D deficiency on body weight, plasma
lipids and vitamin D status of the LDLR2/2 mice. The
body weights of LDLR
2/2 mice that were fed diets with low,
recommended or high levels of vitamin D3 for 16 weeks did not
differ (Table 1). The plasma concentrations of triglycerides and
Figure 1. VDR
2/2 mice have larger calcified lesion areas in their aortic valves than WT mice. Panel A shows representative von Kossa
stained aortic root sections of VDR
2/2 mice fed a rescue diet, WT mice fed a rescue diet (WTRD) and WT mice fed a normal calcium/phosphorus diet
(WTND) for 8 weeks (610). The bottom panel shows a magnification of the inserts in the top panel. Panel B shows the relative calcification area of the
aortic sections and panel C the number of small-, medium- and large-sized calcified areas within an aortic cross-section. Data are means 6 SD of 6–9
mice per group.
a,b Bars with different superscript letters differ, P,0.015.
doi:10.1371/journal.pone.0035316.g001
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mice (Table 1). As expected, the vitamin D status of mice,
determined as plasma concentrations of 25(OH)D3,
24,25(OH)2D3, and 1,25(OH)2D3 was strongly influenced by the
vitamin D3 concentrations in the diets (Figure 3; P,0.001). Mice
fed the low vitamin D diet had the lowest plasma concentrations of
25(OH)D3 and 24,25(OH)2D3, followed by mice that received
recommended amounts of vitamin D; the highest plasma levels
were observed in the high vitamin D group. Mice fed the diets with
low and high concentrations of vitamin D had suppressed levels of
circulating 1,25(OH)2D3 compared to mice fed a diet that
contained recommended amounts of vitamin D (Figure 3,
P,0.05). To gain information about the intracellular genomic
effects of vitamin D in response to the vitamin D diet, the aortic
mRNA abundancy of calbindin D9kas a classical target gene of
the bioactive vitamin D was measured. The relative mRNA
concentration of calbindin D9k in the aorta increased with
increasing dietary intake of vitamin D (Figure 3, P,0.05). The
differences in the vitamin D status, however, were not
accompanied by any differences in the concentrations of
calcium, total or inorganic phosphate in plasma and femur
(Table 2).
Impact of a low vitamin D diet on composition of aortic
roots of the LDLR2/2 mice. Data revealed that mice of all
groups developed severe atherosclerosis. Thirty-five to 38% of the
aortic root section areas comprised of plaque lesions (Table 3). The
level of vitamin D in the diet had no influence on the
atherosclerotic plaque sizes (Table 3). However, aortic sections
showed more calcified lesions in mice fed the low vitamin D diet
than in mice fed recommended or high amounts of vitamin D
(+58%, +120%, respectively, Figure 4; P,0.001). Mice treated
with the high vitamin D diet tended to have less aortic calcification
areas (228%) than mice fed recommended amounts (P,0.10).
Figure 4C demonstrate that LDLR
2/2 mice that were fed the low
vitamin D diet had a markedly higher number of calcified spots
within the aortic cross section than LDLR2/2 fed diets with
recommended and high amounts of vitamin D. The increased
number of calcified spots was mainly due to a higher number of
small (,10 mm
2) and medium (10–100 mm
2) spots but not due to a
higher number of large (.100 mm
2) spots. Mean plaque levels of
collagen, lipids, macrophages and smooth muscle cells were not
different between the three groups of LDLR
2/2 mice (Table 3).
Impact of vitamin D deficiency on osteoblast
differentiation factors in aortic roots of the LDLR2/2
mice. Since aortic calcification in the VDR
2/2 mice was
associated with the up-regulation of osteogenic key factors, we
analysed these factors in the LDLR
2/2 mouse model, too. Aortic
Bmp2, Msx2 and Runx2 were higher in the low vitamin D group
Figure 2. VDR knockout increases the expression of osteoblast differentiation factors in aortic valves. Panel A shows representative
aortic root sections immunohistochemically stained for Bmp2, Msx2 and Runx2 from VDR
2/2 mice fed a rescue diet, WT mice fed a rescue diet (WTRD)
and WT mice fed a normal calcium/phosphorus diet (WTND) for 8 weeks (610). Panel B shows the percentage of stained areas relative to the total
cross-section. Data are means 6 SD of 6–9 mice per group.
a,b Bars with different superscript letters differ, P,0.015.
doi:10.1371/journal.pone.0035316.g002
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(P,0.01; Figure 5). Figure 5 shows further no differences of Msx2
and Runx2 between mice fed recommended and high levels of
vitamin D, but mice fed the high vitamin D diet had lower Bmp2
levels than mice fed the recommended amounts (P,0.001).
Discussion
Several studies found strong associations between hypovitamin-
osis D and cardiovascular diseases [4–8]. In the mouse
experiments reported here, VDR knockout and diet-induced
reduction of vitamin D status resulted in enhanced aortic valve
and vascular calcification. Thus, the observed association of low
serum 25(OH)D and high vascular calcifications in humans [15]
appears to be causally linked. The results obtained from the
VDR
2/2 mouse study further revealed that calcification seems to
be independent from other vascular processes because aortic
valves of VDR
2/2 mice became significantly calcified despite any
identifiable atherosclerotic plaques. Vascular calcification is being
associated with reduced arterial elastance, and compromised
structural integrity [16,17]. We assume that the observed vascular
instability during preparation and dissection of aortas from
VDR
2/2 mice was, at least in part, caused by the presence of
more calcified deposits at the level of aortic root compared to the
WT mice. Not all vascular calcification occurs in the presence of
atherosclerosis. Data from our VDR
2/2 mouse study show that
vascular mineralization was not simply the consequence of
accelerated atherosclerosis because calcification occurred in vessel
walls that were free of any atherosclerotic plaques. However, when
considering the number of calcified spots of defined sizes within
the cross sections, data clearly show that VDR
2/2 had not only a
higher number of small-sized spots, but also a higher number of
medium- and large-sized spots compared to WT mice. Similar
findings were observed in the LDLR
2/2 mouse study, in which
mice fed the low vitamin D diet had a higher number of small- and
medium-sized calcified spots than mice fed recommended and
high amounts of vitamin D. However, the number of large-sized
spots was very low in all groups of these mice.
Analyses of human populations at high and moderate risk for
coronary heart disease showed that circulating plasma concentra-
tions of calcitriol were inversely correlated with the extent of
vascular calcification in both groups [18]. Results from the
LDLR
2/2 mouse study revealed that mice fed the high vitamin D
diet had less vascular calcification than mice fed the low vitamin D
diet although plasma levels of 1,25(OH)2D3 were not different
between these two groups. It is well-known that a high intake of
vitamin D might lead to a reduction of plasma calcitriol levels via
down-regulation of renal CYP27B1, an enzyme that converts
25(OH)D to 1,25(OH)2D [19]. We therefore assume that the
described negative correlation between vascular calcification and
plasma calcitriol only applies in cases of low plasma levels of
calcitriol caused by chronic kidney diseases, low cutaneous vitamin
D synthesis or low intake of dietary vitamin D but not in cases of
reduced calcitriol levels induced by high vitamin D intake. Thus,
intake of high doses of native vitamin D may differ in its effects on
cardiovascular calcification when compared with high-doses of
active vitamin D, i.e. calcitriol, since the levels of 1,25(OH)2D are
not the same in these two states. Although the circulating
concentrations of 25(OH)D, and 24,25(OH)2D and the vascular
mRNA concentration of calbindin D9k reflect quite well the
vitamin D status, levels beyond those obtained with recommended
Figure 3. Vitamin D status of LDLR
2/2 mice in response dietary
vitamin D levels. Plasma concentrations of 25(OH)D3, 24,25(OH)2D3,
1,25(OH)2D3, and relative mRNA abundancy of aortic calbindin D9kof
LDLR
2/2 mice fed a Western diet with low (50 IU/kg), recommended
(1,000 IU/kg), or high (10,000 IU/kg) levels of vitamin D3 for 16 weeks.
Data are means 6 SD of 4 probes per group (pools of 3 samples) for
analysis of 1,25(OH)2D3 and 12 mice per group for all other analyses.
a,b,c
Bars with different superscript letters differ, P,0.05.
doi:10.1371/journal.pone.0035316.g003
Table 1. Final body weights and plasma lipid levels of
LDLR
2/2 mice in fed low, recommended or high amounts of
vitamin D3 with their diets.
Dietary vitamin D3 concentrations
50 IU/kg 1,000 IU/kg 10,000 IU/kg
Final body weight (g) 28.562.1 27.962.9 26.862.2
Plasma triglycerides (mmol/L) 1.8360.68 2.0060.70 1.8560.86
Plasma cholesterol (mmol/L) 29.364.6 28.364.7 28.167.0
Values are means 6 SD (n=12 per group).
doi:10.1371/journal.pone.0035316.t001
Table 2. Calcium and phosphorus concentrations of plasma
and femur of LDLR
2/2 mice in fed low, recommended or high
amounts of vitamin D3 with their diets.
Dietary vitamin D3 concentrations
50 IU/kg 1,000 IU/kg 10,000 IU/kg
Plasma
Calcium (mmol/L) 1.9360.20 1.9960.21 1.8560.26
Total phosphorus (mmol/L) 11.561.1 11.861.4 11.962.0
Inorganic phosphate (mmol/L) 4.2061.00 4.5661.38 4.3861.59
Femur
Calcium (g/kg DM) 235612 237652 3 6 65
Total phosphorus (g/kg DM) 114661 1 5 621 1 4 62
Values are means 6 SD (n=12 per group); DM, dry matter.
doi:10.1371/journal.pone.0035316.t002
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reduction of vascular calcification. Thus, the biphasic dose-
response curve of vitamin D on vascular calcification may not
necessarily be applicable to native dietary vitamin D.
Arterial calcification is a common feature of atherosclerosis
[20,21] and is supposed to contribute to an increased risk of
vascular dissection during angioplasty [22], myocardial infarction
[23] and mortality in patients with advanced atherosclerosis [24].
Vascular calcification is a complex process that involves numerous
regulating factors and seems to share many similarities to skeletal
mineralization and osteogenesis [25] because vascular smooth
muscle cells and osteoblasts derive from the same mesenchymal
precursor cell. Morphogenetic proteins Runx2, Msx2 and Bmp2
are involved in the transformation of vascular smooth muscle cells
into osteoblast-like cells [26–28]. Results from our experiments
indicate that the increased calcification of VDR
2/2 mice and
LDLR
2/2 mice that received the low vitamin D diet was driven
by these morphogenic proteins, because aortic Runx2, Msx2, and
Bmp2 were up-regulated in these animals. Bmp2 has been
identified as a crucial mediator of calcification because it up-
regulates Msx2 and Runx2 which are key regulators of osteoblastic
differentiation [29]. Runx2 expression in vascular smooth muscle
cells has been considered identified as an early marker of
osteoblastic differentiation, the initial step in vascular calcification
[29]. Several factors that contribute to vascular calcification
induce Runx2 expression, including increased inorganic phos-
phate concentration [30,31]. The classical function of active
vitamin D is to maintain the homeostasis of calcium and
phosphorus and to keep their concentrations in the plasma
constant. The findings that the circulating plasma concentration of
inorganic phosphate did not differ between the VDR
2/2 and WT
mice, as well as among the LDLR2/2 mice reveal that calcium
Table 3. Aortic plaque area size and plaque composition of
aortic roots in LDLR
2/2 mice fed low, recommended or high
amounts of vitamin D3 with their diets.
Dietary vitamin D3 concentrations
50 IU/kg 1,000 IU/kg 10,000 IU/kg
Plaque area (% of aortic cross section) 34.867.5 36.168.5 37.666.0
Plaque collagen (%) 59.965.0 57.8612.9 55.866.4
Plaque lipids (%) 11.362.3 11.461.8 11.562.4
Plaque macrophages (%) 33.168.7 31.464.0 28.865.4
Plaque smooth muscle cells (%) 7.9562.53 9.8062.99 7.9163.46
Values are means 6 SD (n=12 per group).
doi:10.1371/journal.pone.0035316.t003
Figure 4. Low vitamin D diet stimulates the development of aortic calcification in LDLR
2/2 mice. Panel A shows representative von Kossa
stained aortic sections from LDLR
2/2 mice kept for 16 weeks on a Western diet with either low (50 IU/kg), recommended (1,000 IU/kg) or high
(10,000 IU/kg) vitamin D3 levels (610). The bottom panel shows a magnification of the inserts in the top panel. Panel B shows the relative calcification
area of the aortic sections and panel C the number of small-, medium- and large-sized calcified areas within an aortic cross-section. Data are means 6
SD of 12 mice per group.
a,b Bars with different superscript letters differ, P,0.015.
doi:10.1371/journal.pone.0035316.g004
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vascular calcification in the vitamin D deficiency state.
In conclusion, our findings show that VDR deficiency and diets
low in vitamin D promote aortic valve and aortic vessel
calcification in the VDR
2/2 and LDLR
2/2 mouse models. The
vascular calcification was associated with an up-regulation of
osteoblast transcription factors which could have triggered the
differentiation of vascular cells into osteoblast-like cells. We assume
that an optimization of circulating 25(OH)D levels therefore could
contribute to prevent vascular and aortic valve calcification and in




All animal experiments described were carried out in accor-
dance with established guidelines for the care and handling of
laboratory animals and were approved by the council of Saxony-
Anhalt (Permit number: 42502-5-34 MLU). Two studies were
conducted. Animals were housed in cages on a 12-h-light/-dark
cycle and consumed food and water ad libitum. Body weights and
food intake were recorded weekly.
In the first experiment, male 5-weeks-old VDR
2/2 mice
(B6.129S4-Vdr
tmlMbd/J; Jackson Laboratory, Bar Harbor, Maine,
USA) and corresponding WT mice (C57BL/6J; Charles River
Laboratories, Sulzfeld, Germany) were fed a semi-synthetic Western
diet (20% sucrose, 20% coconut oil, 0.15% cholesterol) for 8
weeks. The VDR
2/2 group (n=6) was maintained on a high-
calcium (2%), high-phosphorus (1.25%) rescue diet to prevent
hypocalcaemia secondary to VDR deficiency. One group of WT
mice (WTRD, n=8) received the same rescue diet as the VDR
2/2
group. The other group of WT mice (WTND, n=8) received a
normal calcium/normal phosphorus diet (0.3% calcium, 0.156%
phosphorus) according to the recommendations of the National
Research Council (NRC) [32] Each group received 20% lactose
with their diet to improve intestinal calcium uptake.




were assigned to three groups of 12 mice each and were fed a
semi-synthetic Western diet (20% sucrose, 21% lard, 0.15%
cholesterol) containing either 50 (low), 1,000 (recommended
[32]), or 10,000 (high) IU vitamin D3/kg diet for 16 weeks. The
other vitamins and minerals were supplemented according to
recommendations of the NRC [32].
Figure 5. Low vitamin D diet increases the expression of vascular osteoblast differentiation factors in LDLR
2/2 mice. Panel A shows
representative aortic cross sections immunohistochemically stained for Bmp2, Msx2 and Runx2 from LDLR
2/2 mice kept for 16 weeks on a Western
diet with either low (50 IU/kg), recommended (1,000 IU/kg) or high (10,000 IU/kg) vitamin D3 levels (610). Panel B shows the percentage of stained
areas relative to the total cross-section. Data are means 6 SD of 12 mice per group.
a,b,c Bars with different superscript letters differ, P,0.015.
doi:10.1371/journal.pone.0035316.g005
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Mice were deprived of food overnight prior to killing under light
anesthesia with diethyl ether. Blood was collected into EDTA
tubes. Plasma was separated by centrifugation at 15006g for
20 min and stored at 220uC until further analysis. Aortic roots
were harvested of all mice for histochemical and immunohisto-
chemical analysis. From LDLR
2/2 mice, femur was excised for
calcium and phosphorus analysis. All tissue samples were
immediately snap-frozen in liquid N2 and stored at 280uC.
Analysis of Plasma 25(OH)D3, 24,25(OH)2D3 and
1,25(OH)2D3
Analysis of 25(OH)D3 and 24,25(OH)2D3 was done by a
modified HPLC-MS/MS method [33] using an API 2000
(ABSCIEX, Darmstadt, Germany) in ESI mode coupled to an
1100 HPLC and Hypersil ODS column (10062.1 mm
2,5mm,
Agilent Technologies, Waldbronn, Germany). Sample preparation
was modified by mixing 50 mL of plasma and 50 mL of internal
standard (25 mg/L 25(OH)D3-d6, Chemaphor Inc., Ottawa,
Canada) in acetonitrile, followed by extraction with 400 mLn -
hexane. After evaporation, 50 mL of 4-phenyl-1,2,4-triazoline-3,5-
dione (0.15 g/L) in acetonitrile were added and incubated
overnight. The samples were then mixed with 20 mL of ethanol,
incubated for 30 min and dried under vacuum afterwards. The
residues were dissolved in 40 mL of the mobile phase. Multilevel
Serum Calibrator Set (Chromsystems, Munich, Germany) and
horse serum spiked with 24,25(OH)2D3 (Enzo Life Sciences,
Lo ¨rrach, Germany) were used for calibration. Plasma concentra-
tion of 1,25(OH)2D3 was determined by use of a commercial
enzyme immunoassay (IDS, Boldon, UK).
Analysis of Calcium and Phosphorus in Plasma and
Femur
The concentration of calcium and total phosphorus (organic
and inorganic) in plasma and femur was measured by inductively
coupled plasma optical emission spectrometry (ICP-OES, Varian
715-ES ICP Optical Emission Spectrometer, Agilent Technolo-
gies, Santa Clara, California, USA; ICP Expert II Varian 715-ES
Instrument Software, Version 1.1.3) using argon as carrier gas.
Prior to analysis of calcium and phosphorus at selected
wavelengths, femurs were ashed in a muffle furnace at 550uC
and dissolved in HCl and HNO3 according to the official
VDLUFA method [34]. After evaporation, the minerals were
resolved in distilled water, filtered and injected in the ICP-OES
system. The plasma concentration of inorganic phosphate was
measured spectrophotometrically according to the manufacturers’
protocol (Fluitest PHOS; Biocon Diagnostik, Vo ¨hl/Marienhagen,
Germany).
Analysis of Triglycerides and Cholesterol in Plasma
Concentrations of triglycerides and cholesterol in plasma were
examined using enzymatic reagent kits (DiaSys Diagnostic
Systems, Holzheim, Germany, no. 1.1300 99 90 314 and 1.5760
99 90 314).
Preparation and Morphometric Analysis of Aortic Roots
For preparation of the aortic root sections, the vasculature was
perfused with 0.9% NaCl, and the ventricular edge and
approximately 1 mm of the aortic root were immediately dissected
under a stereomicroscope and cryo-mounted in mounting medium
(tissue freezing mediumH, Jung; Leica Instruments, Nussloch,
Germany). To quantify atherosclerosis at the aortic root, serial
7 mm thick slices (CM 1850 UV microtome, Jung; Leica) were
collected, beginning at the aortic valve area. Four sections each
were stained with haematoxylin-eosin (sections from 0 to 28 mm),
Mallory-Cason’s trichrome for collagen structures (sections from
112 to 140 mm), von Kossa for vascular calcification (sections from
154 to 182 mm) and Oil red O for vascular lipids (sections from
196 to 224 mm). Histomorphological characterization and com-
puterized morphometric quantification (Axiovert 200 microscope;
AxioCamMRc; Axiovision Rel. 4.8.2 software (all Carl Zeiss, Jena,
Germany)) of the atherosclerotic lesions were performed. The
cross-sectional surface area of the total vessel, the atherosclerotic
lesion area as well as the calcification area, the collagen area and
the lipid area were assessed to characterize atherosclerosis
development in the aortic root.
Immunohistochemical Analysis of Aortic Roots
For immunohistochemistry aortic root sections were immedi-
ately fixed in acetone at 220uC for 10 min, and endogenous
peroxidase was blocked with 0.3% H2O2 in methanol. Following a
washing step, the sections were incubated each with 5% blocking
serum in PBS at room temperature for 20 min. Sections were
incubated with primary antibodies against CD68 (AbD Serotec,
Oxford, UK; sections from 28 to 56 mm), SMC a-actin (Sigma-
Aldrich, Taufkirchen, Germany; sections from 56 to 84 mm),
Bmp2 (abcam, Cambridge, UK; sections from 84 to 112 mm),
Runx2 (antibodies-online.de, Atlanta, USA; sections from 140 to
154 mm ) and Msx2 (Sigma-Aldrich; sections from 182 to 196 mm)
over night at 4uC, followed by incubation with horseradish
peroxidase-labeled secondary antibodies (goat anti-rat IgG
(AbDSerotec, Oxford, UK) and rabbit anti-mouse IgG (Dako,
Hamburg, Germany) at room temperature for 30 min. The
immunocomplex was visualized using diaminobenzidine chromo-
gen (Dako). Sections were counterstained with Harris haematox-
ylin solution. Stained slices were evaluated for the presence and
intensity of positive reaction using Axiovision Rel. 4.8.2 software.
RNA Isolation and real time RT-PCR
For the determination of aortic calbindin D9k mRNA
expression level, total RNA was isolated from the aortic arch
using TrizolTM reagent (Invitrogen, Karlsruhe, Germany)
according to the manufacturer’s protocol. RNA concentration
and purity were estimated from the optical density at 260 and
280 nm, respectively. Total RNA (1.2 mg) was subjected to first-
strand cDNA synthesis at 42uC for 60 min using M-MuLV RT
(MBI Fermentas, St. Leon-Rot, Germany) and oligo dT18-primer
(Operon Biotechnologies, Cologne, Germany). PCR was per-
formed with the Rotor Gene 2000 system (Corbett Research,
Mortlake, Australien). Real-time detection was carried out by
using SYBRH Green I (Sigma), 1.25 U Taq DNA polymerase
(Promega, Mannheim, Germany), 500 mM dNTP and 26.7 pmol
of specific primers for calbindin D9k (NM_009789.2; forward
59TCA CCT GCT GTT CCT GTC TG 39; reverse 59 TCG
CCA TTC TTA TCC AGC TC 39, Operon Biotechnologies).
Each PCR cycle compromised denaturation for 20 s at 95uC,
annealing for 30 s at 60uC and elongation at 72uC for 55 s. At the
end of the elongation step, the intensity of fluorescence in all
probes was measured. The threshold cycle (Ct) and the
amplification efficiency were obtained from each amplification
curve using the software RotorGene 4.6 (Corbett Research). For
identification of the PCR products, melting-curve analysis and
agarose (1.5%) gel electrophoresis were performed. The house-
keeping gene b-actin (NM_007393.2; forward 59ACG GCC AGG
TCA TCA CTA TTG 39; reverse 59 CAC AGG ATT CCA TAC
CCA AGA AG 39, Operon Biotechnologies) was used for
normalization.
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Values presented in the text are means and standard deviations.
Treatment effects were analyzed by one-way ANOVA using
MINITAB software (Minitab, State College, PA, USA). For
statistically significant F values, means were compared by Fisher’s
multiple-comparison test. Means were considered to be signifi-
cantly different at P,0.05.
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